Cargando…

Reply to Alizazgar J. Dangers of the use of hydroxychloroquine and azithromycin combination in COVID-19 patients

Detalles Bibliográficos
Autores principales:	Honoré, Stéphane, Gautret, Philippe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2021
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7862014/ https://www.ncbi.nlm.nih.gov/pubmed/33549822 http://dx.doi.org/10.1016/j.tmaid.2021.101984

Ejemplares similares

Dangers of the use of hydroxychloroquine and azithromycin combination in COVID-19 patients
por: Alizargar, Javad
Publicado: (2020)

Safety profile of hydroxychloroquine and azithromycin combined treatment in COVID-19 patients
por: Gautret, Philippe, et al.
Publicado: (2021)

Response to the use of hydroxychloroquine in combination with azithromycin for patients with COVID-19 is not supported by recent literature.
por: Gautret, Philippe, et al.
Publicado: (2021)

Clinical efficacy and safety profile of hydroxychloroquine and azithromycin against COVID-19
por: Gautret, Philippe, et al.
Publicado: (2021)

Hydroxychloroquine-azithromycin for COVID-19 – Warranted or dangerous?
por: Popescu, Corneliu P., et al.
Publicado: (2020)

Combination of Hydroxychloroquine Plus Azithromycin As Potential Treatment for COVID-19 Patients: Safety Profile, Drug Interactions, and Management of Toxicity
por: Hache, Guillaume, et al.
Publicado: (2021)

Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open label non-randomized clinical trial revisited
por: Gautret, Philippe, et al.
Publicado: (2021)

Reply to Lebeaux D, Revest M. No evidence of clinical benefits of early treatment of COVID-19 patients with hydroxychloroquine and azithromycin
por: Million, Matthieu, et al.
Publicado: (2021)

Hydroxychloroquine + azithromycin treatment in elderly patients
por: Gautret, Philippe, et al.
Publicado: (2021)

Azithromycin for mild-to-moderate COVID-19 – Authors' reply
por: Hinks, Timothy S C
Publicado: (2021)

Conflicting evidence on the efficacy of hydroxychloroquine and azithromycin as the early treatment of COVID-19. Comment on “Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France”
por: Bonny, Aimé, et al.
Publicado: (2020)

WITHDRAWN: Early combination therapy with hydroxychloroquine and azithromycin reduces mortality in 10,429 COVID-19 outpatients
por: Million, Matthieu, et al.
Publicado: (2021)

Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial
por: Gautret, Philippe, et al.
Publicado: (2020)

Apparent inefficacy of hydroxychloroquine combined with azithromycin on SARS-CoV-2 clearance in an incident cohort of geriatric patients with COVID-19
por: Mazzitelli, Maria, et al.
Publicado: (2020)

Use of hydroxychloroquine and azithromycin combination to treat the COVID-19 infection
por: Bajpai, Jyoti, et al.
Publicado: (2022)

Effect of hydroxychloroquine and azithromycin on SARS-CoV-2 clearance in COVID-19 patients, a meta-analysis.
por: Million, Matthieu, et al.
Publicado: (2021)

Claims about the safety and efficacy of early treatment of COVID-19 with hydroxychloroquine and azithromycin must be supported by real evidence
por: Bigna, Jean Joel, et al.
Publicado: (2020)

Treatment with hydroxychloroquine, azithromycin, and combination in patients hospitalized with COVID-19
por: Arshad, Samia, et al.
Publicado: (2020)

Cardiovascular Toxicities Associated With Hydroxychloroquine and Azithromycin: An Analysis of the World Health Organization Pharmacovigilance Database
por: Nguyen, Lee S., et al.
Publicado: (2020)

Effect of hydroxychloroquine and azithromycin on the viral clearance of SARS-CoV-2: response to Hervé Seligmann
por: Gautret, Philippe, et al.
Publicado: (2021)

Hydroxychloroquine treatment does not reduce COVID-19 mortality; underdosing to the wrong patients? – Authors' reply
por: Rentsch, Christopher T, et al.
Publicado: (2021)

Outcomes of 3,737 COVID-19 patients treated with hydroxychloroquine/azithromycin and other regimens in Marseille, France: A retrospective analysis
por: Lagier, Jean-Christophe, et al.
Publicado: (2020)

Use of hydroxychloroquine in combination with azithromycin for patients with COVID-19 is not supported by recent literature
por: Goldman, Jason D., et al.
Publicado: (2021)

Cardiovascular Safety of Hydroxychloroquine–Azithromycin in 424 COVID-19 Patients
por: Million, Matthieu, et al.
Publicado: (2023)

Will Hydroxychloroquine Still Be a Game-Changer for COVID-19 by Combining Azithromycin?
por: Li, Chunfeng, et al.
Publicado: (2020)

Effect of Combination Therapy of Hydroxychloroquine and Azithromycin on Mortality in Patients With COVID‐19
por: Lauriola, Marinella, et al.
Publicado: (2020)

Response to uncertain effect of hydroxychloroquine and azithromycin on SARS-CoV-2 viral load.
por: Gautret, Philippe, et al.
Publicado: (2021)

Hydroxychloroquine and azithromycin as a treatment of COVID-19
por: Fanin, Alice, et al.
Publicado: (2020)

Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France
por: Million, Matthieu, et al.
Publicado: (2020)

Reply to Gautret et al: hydroxychloroquine sulfate and azithromycin for COVID-19: what is the evidence and what are the risks?
por: Machiels, Julian D, et al.
Publicado: (2020)

Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID-19 patients with at least a six-day follow up: A pilot observational study
por: Gautret, Philippe, et al.
Publicado: (2020)

Azithromycin for mild-to-moderate COVID-19
por: Patel, Jigar, et al.
Publicado: (2021)

Problems with the analysis in “Treatment with Hydroxychloroquine, Azithromycin, and Combination in Patients Hospitalized with COVID-19”
por: Atkinson, J. Graham
Publicado: (2020)

Effects of cardiac toxicity of combination therapy with hydroxychloroquine and azithromycin in COVID-19 patients
por: Yendrapalli, Usha, et al.
Publicado: (2021)

Impact of Azithromycin and/or Hydroxychloroquine on Hospital Mortality in COVID-19
por: Albani, Filippo, et al.
Publicado: (2020)

Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19
por: Cavalcanti, Alexandre B., et al.
Publicado: (2020)

COVID-19, Guillain-Barré syndrome, and the vaccine. A dangerous combination()
por: Aomar-Millán, I.F., et al.
Publicado: (2021)

Effect of hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial, an update with an intention-to-treat analysis and clinical outcomes
por: Gautret, Philippe, et al.
Publicado: (2021)

Dr. Hayd Replies to J. P. and J. H.
por: Hayd, H. E.
Publicado: (1890)

Chloroquine or hydroxychloroquine for prophylaxis of COVID-19
por: Principi, Nicola, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_dlsr98sdcq8c6lm9bchbh2ckot